Literature DB >> 19060497

Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma.

H Mehmet Turk1, Ahmet Ozet, Okan Kuzhan, Ferhan Komurcu, Fikret Arpaci, Bekir Ozturk, Selmin Ataergin.   

Abstract

OBJECTIVE: To report an unusual paraneoplastic syndrome, amyotrophic lateral sclerosis, associated with renal cell carcinoma. CASE PRESENTATION AND INTERVENTION: A 59-year-old man presented with muscle weakness and fasciculations in the upper extremities. Neurological examination showed that the fasciculations arose spontaneously in the upper limbs. Electrodiagnostic studies revealed an active neurogenic disorder. The patient was diagnosed with a motor neuron disease mimicking amyotrophic lateral sclerosis. Urine analysis revealed microscopic hematuria. Abdominal computerized tomography scans showed a 9.5 x 8 cm renal mass in the lower pole of the right kidney. Curative right radical nephrectomy was performed. Pathologic examination showed a clear cell adenocarcinoma. After nephrectomy, the muscle weakness and fasciculations disappeared spontaneously within 2 months. The patient was disease-free for 58 months after right radical nephrectomy. He complained of muscle weakness and fasciculation at the last follow-up again. Physical examination revealed fasciculation in the upper limbs. Abdominal tomography showed a 22 x 20 mm solid mass in the lower pole of the left kidney. Kidney-saving surgery was performed and the diagnosis of renal cell carcinoma was confirmed pathologically. Following surgery, fasciculations completely disappeared and muscle weakness diminished within 3 months.
CONCLUSION: This case highlights motor neuron disease as a rare paraneoplastic syndrome in association with renal cell carcinoma and resolution after removal of the tumor. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 19060497     DOI: 10.1159/000163053

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  8 in total

1.  Paraneoplastic neurological syndromes: general treatment overview.

Authors:  Aurélien Viaccoz; Jérôme Honnorat
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

Review 2.  Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma.

Authors:  M Hegemann; N Kroeger; A Stenzl; J Bedke
Journal:  World J Urol       Date:  2018-02-10       Impact factor: 4.226

3.  Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.

Authors:  Macarena Villagrán-García; Sergio Muñiz-Castrillo; Nicolás Lundahl Ciano-Petersen; Alberto Vogrig; Antonio Farina; Marine Villard; Dimitri Psimaras; Agusti Alentorn; David Gonçalves; Nicole Fabien; Véronique Rogemond; Bastien Joubert; Jérôme Honnorat
Journal:  J Neurol       Date:  2022-09-01       Impact factor: 6.682

4.  Progressive Global Ataxia With Sensory Changes as a Paraneoplastic Syndrome in a Patient With Chromophobe Renal Cell Carcinoma.

Authors:  Mustafa M Basree; Raquel Rudy; Cristina Romaniello; Daniel E Smith; Elizabeth Kander
Journal:  Cureus       Date:  2022-05-11

5.  Paraneoplastic Peripheral Nervous System Manifestations of Renal Cell Carcinoma: A Case Report and Review of the Literature.

Authors:  Ingrid Yang; Joanna Jaros; Danny Bega
Journal:  Case Rep Neurol       Date:  2017-02-20

6.  Use of sugammadex in a patient with amyotrophic lateral sclerosis.

Authors:  Ebru Kelsaka; Deniz Karakaya; Eyüp Cağatayn Zengin
Journal:  Med Princ Pract       Date:  2012-10-13       Impact factor: 1.927

7.  Nonmetastatic renal cell carcinoma presenting with persistent cough: Case report with literature review.

Authors:  Mohd Amer Alsamman; David Draper
Journal:  Avicenna J Med       Date:  2019-10-03

8.  Guillain-Barre syndrome: a typical paraneoplastic syndrome in a kidney transplant recipient with allograft renal cell carcinoma: a case report and review of the literature.

Authors:  Izabela Zakrocka; Iwona Baranowicz-Gąszczyk; Agnieszka Korolczuk; Wojciech Załuska
Journal:  BMC Nephrol       Date:  2020-10-14       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.